Clinical Trials in Denver

Showing 5521-5540 of 13,773 trials

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

NCT02718911

The main purpose of this study is to evaluate the safety of the colony-stimulating factor 1 receptor (CSF-1R) inhibitor LY3022855 in combination with durvalumab or tremelimumab in participants with advanced solid tumors.

Solid Tumor

Eli Lilly and Company72 participantsStarted Jun 2016

Denver, Colorado, United States • Sarasota, Florida, United States • Atlanta, Georgia, United States +11 more locations

COMPLETEDPhase 18.4 miles

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

NCT02780804

This phase I trial studies the side effects and best dose of entinostat in treating pediatric patients with solid tumors that have come back or have not responded to treatment. Entinostat may block some of the enzymes needed for cell division and it may help to kill tumor cells.

Brain Stem NeoplasmPineal Region NeoplasmRecurrent Lymphoma+7 more

National Cancer Institute (NCI)21 participantsStarted Jan 2017

Birmingham, Alabama, United States • Los Angeles, California, United States • Orange, California, United States +18 more locations

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Find Trials by Condition in Denver

Improving Physical Activity Maintenance of Cancer Survivors

A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy

Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)

Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection

Neurolens Headache Study

A Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps

TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.

A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

In-Stent Restenosis Post-Approval Study

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants

FoxBioNet: ECV (Extracellular Vesicle) 004